Citius Oncology (CTOR) Shares Issued (2023 - 2026)
Citius Oncology (CTOR) posted quarterly Shares Issued of $18.1 million for Q1 2026, up 252.45% year-over-year from $5.1 million in Q1 2025, and little changed quarter-over-quarter from $18.1 million in Q4 2025.
Citius Oncology (CTOR) Shares Issued (2023 - 2026) Analysis & Trends
Citius Oncology (CTOR) has reported Shares Issued for 4 consecutive years, with $18.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Issued rose 252.45% year-over-year to $18.1 million; the TTM figure through Mar 2026 stood at $18.1 million (up 252.45% YoY), while the FY2025 annual figure was $18.1 million, up 41.96% from the prior year.
- Shares Issued held at $18.1 million in Q1 2026 per CTOR's latest filing, from $18.1 million in the prior quarter.
- Across five years, Shares Issued topped out at $18.1 million in Q3 2025 and bottomed at $4.8 million in Q4 2024.
- Historically, Shares Issued has averaged $11.9 million across 4 years, with a median of $12.7 million in 2023.
- Annual changes were most pronounced in 2024 — Shares Issued grew 1.19% — and 2025, when it jumped 281.05%.
- Citius Oncology's Shares Issued stood at $12.6 million in 2023, then tumbled by 62.3% to $4.8 million in 2024, then surged by 281.05% to $18.1 million in 2025, then changed by 0.0% to $18.1 million in 2026.
- Business Quant data shows CTOR's Shares Issued at $18.1 million in Q1 2026, $18.1 million in Q4 2025, and $18.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Citius Oncology | 81.99 Mn | 81.99 Mn | 1.00 Mn | 18.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.10 Mn |
| Mar 31, 2026 | 18.10 Mn |
| Dec 31, 2025 | 18.10 Mn |
| Dec 31, 2025 | 18.10 Mn |
| Sep 30, 2025 | 18.10 Mn |
| Sep 30, 2025 | 18.10 Mn |
| Jun 30, 2025 | 5.55 Mn |
| Jun 30, 2025 | 5.55 Mn |
| Mar 31, 2025 | 5.14 Mn |
| Mar 31, 2025 | 5.14 Mn |
| Dec 31, 2024 | 4.75 Mn |
| Dec 31, 2024 | 4.75 Mn |
| Sep 30, 2024 | 12.75 Mn |
| Sep 30, 2024 | 12.75 Mn |
| Sep 30, 2023 | 12.60 Mn |
| Sep 30, 2023 | 12.60 Mn |